Vyome director granted 120K options at $2.17
Vyome Holdings director Mohanjit Jolly received a fully vested grant of 120,000 stock options at a $2.17 exercise price expiring in 2036.
Rhea-AI Filing Summary
Vyome Holdings, Inc (HIND) reported that director Mohanjit Jolly received a grant of stock options on September 1, 2026. The grant covers 120,000 options to purchase Vyome common stock at an exercise price of $2.17 per share under the company’s 2025 Equity Incentive Plan. The options are fully vested and expire on September 1, 2036, bringing Jolly’s directly held derivative position to 137,833 options after the grant. No Rule 10b5-1 trading plan is reported for this award.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 120,000 shares
Grant/Award
1 txn
Insider
Jolly Mohanjit
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 120,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 137,833 contracts (Direct)
Footnotes (1)
- F1. On September 1, 2026 the reporting person was granted an option to purchase 120,000 shares of the Issuer's common stock pursuant to the Issuer's 2025 Equity Incentive Plan. The shares subject to the option are fully vested.
Key Figures
Options granted: 120,000 options
Exercise price: $2.17 per share
Expiration date: September 1, 2036
+3 more
6 metrics
Options granted
120,000 options
Stock option grant to director Mohanjit Jolly on September 1, 2026
Exercise price
$2.17 per share
Conversion or exercise price of the granted stock options
Expiration date
September 1, 2036
Expiration of the 120,000 granted stock options
Post-grant derivative holdings
137,833 options
Total stock options held directly by Mohanjit Jolly after the transaction
Vested options in grant
120,000 options
All shares subject to the September 1, 2026 option grant are fully vested
Rule 10b5-1 plan status
No plan reported
Affirmative 10b5-1 checkbox is not marked for this Form 4
Key Terms
Stock Option (right to buy), 2025 Equity Incentive Plan, exercise price, expiration date
4 terms
Stock Option (right to buy) financial
"Reports a security titled Stock Option (right to buy) as the derivative"
2025 Equity Incentive Plan financial
"Granted pursuant to the Issuer's 2025 Equity Incentive Plan"
exercise price financial
"Shows a conversion or exercise price of 2.1700 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"Lists an expiration date of 2036-09-01 for the option"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transaction did Vyome Holdings (HIND) report for Mohanjit Jolly?
Vyome Holdings reported that director Mohanjit Jolly received a grant of 120,000 stock options on September 1, 2026. The options allow him to purchase Vyome common stock at an exercise price of $2.17 per share and are fully vested at grant.
What is the exercise price and term of the new Vyome (HIND) stock options?
The granted stock options have an exercise price of $2.17 per share and an expiration date of September 1, 2036. They were issued under Vyome’s 2025 Equity Incentive Plan and are fully vested as of the grant date.
How many Vyome (HIND) derivative securities does Mohanjit Jolly hold after this Form 4?
Following the reported grant, Mohanjit Jolly holds 137,833 stock options directly. The reported transaction reflects an acquisition of 120,000 new options, increasing his derivative holdings to this post-transaction amount.
Are the new Vyome (HIND) stock options for Mohanjit Jolly vested?
Yes. The footnote states that the option to purchase 120,000 shares of Vyome common stock is fully vested as of the grant on September 1, 2026, meaning all 120,000 underlying shares are immediately exercisable under the plan terms.
Was the Vyome (HIND) option grant to Mohanjit Jolly made under a Rule 10b5-1 plan?
No. The filing’s Rule 10b5-1 checkbox is not checked, and the footnote does not reference any such trading plan. The reported transaction is a compensation-related option grant under the 2025 Equity Incentive Plan, not a sale or purchase under a trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
